mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking.
Therefore, we investigated the demographics, management, and prognosis of new R-IMIDs
in adults following SARS-CoV-2 vaccinations. A systematic literature search of Medline,
Embase, Google Scholar, LitCovid, and Cochrane was conducted. We included any English-
language study that reported new-onset R-IMID in adults following the post-COVID-19 …